Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges.

Himes BT, Zhang L, Daniels DJ.

Front Oncol. 2019 Feb 8;9:31. doi: 10.3389/fonc.2019.00031. eCollection 2019. Review.

2.

Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.

Sewing ACP, Lagerweij T, van Vuurden DG, Meel MH, Veringa SJE, Carcaboso AM, Gaillard PJ, Peter Vandertop W, Wesseling P, Noske D, Kaspers GJL, Hulleman E.

J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17.

PMID:
28291423
3.

Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.

Zhou Z, Singh R, Souweidane MM.

Curr Neuropharmacol. 2017;15(1):116-128.

4.

Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.

Sewing AC, Caretti V, Lagerweij T, Schellen P, Jansen MH, van Vuurden DG, Idema S, Molthoff CF, Vandertop WP, Kaspers GJ, Noske DP, Hulleman E.

J Neurosci Methods. 2014 Dec 30;238:88-94. doi: 10.1016/j.jneumeth.2014.09.020. Epub 2014 Sep 27.

PMID:
25263805
5.

Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes.

Huang T, Garcia R, Qi J, Lulla R, Horbinski C, Behdad A, Wadhwani N, Shilatifard A, James C, Saratsis A.

Oncotarget. 2018 Dec 14;9(98):37112-37124. doi: 10.18632/oncotarget.26430. eCollection 2018 Dec 14.

6.

Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.

Ivasyk I, Morgenstern PF, Wembacher-Schroeder E, Souweidane MM.

J Neurosurg Pediatr. 2017 Sep;20(3):256-260. doi: 10.3171/2017.5.PEDS1774. Epub 2017 Jul 7.

PMID:
28686124
7.

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas.

Welby JP, Kaptzan T, Wohl A, Peterson TE, Raghunathan A, Brown DA, Gupta SK, Zhang L, Daniels DJ.

Front Oncol. 2019 Feb 27;9:92. doi: 10.3389/fonc.2019.00092. eCollection 2019.

8.

Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.

Anderson RC, Kennedy B, Yanes CL, Garvin J, Needle M, Canoll P, Feldstein NA, Bruce JN.

J Neurosurg Pediatr. 2013 Mar;11(3):289-95. doi: 10.3171/2012.10.PEDS12142. Epub 2012 Dec 14.

PMID:
23240851
9.

Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.

Heiss JD, Jamshidi A, Shah S, Martin S, Wolters PL, Argersinger DP, Warren KE, Lonser RR.

J Neurosurg Pediatr. 2018 Dec 7;23(3):333-342. doi: 10.3171/2018.9.PEDS17225.

PMID:
30544335
10.

The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.

Singleton WGB, Bienemann AS, Woolley M, Johnson D, Lewis O, Wyatt MJ, Damment SJP, Boulter LJ, Killick-Cole CL, Asby DJ, Gill SS.

J Neurosurg Pediatr. 2018 Sep;22(3):288-296. doi: 10.3171/2018.2.PEDS17663. Epub 2018 Jun 1.

PMID:
29856296
11.

Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).

Gwak HS, Park HJ.

Crit Rev Oncol Hematol. 2017 Dec;120:111-119. doi: 10.1016/j.critrevonc.2017.10.013. Epub 2017 Oct 31. Review.

PMID:
29198324
12.

Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.

Castel D, Philippe C, Kergrohen T, Sill M, Merlevede J, Barret E, Puget S, Sainte-Rose C, Kramm CM, Jones C, Varlet P, Pfister SM, Grill J, Jones DTW, Debily MA.

Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1.

13.

Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.

El-Khouly FE, van Vuurden DG, Stroink T, Hulleman E, Kaspers GJL, Hendrikse NH, Veldhuijzen van Zanten SEM.

Front Oncol. 2017 Oct 30;7:254. doi: 10.3389/fonc.2017.00254. eCollection 2017.

14.

Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.

Saito R, Tominaga T.

Neurol Med Chir (Tokyo). 2017 Jan 15;57(1):8-16. doi: 10.2176/nmc.ra.2016-0071. Epub 2016 Dec 15. Review.

15.

A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.

Guisado DI, Singh R, Minkowitz S, Zhou Z, Haque S, Peck KK, Young RJ, Tsiouris AJ, Souweidane MM, Thakur SB.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1367-73. doi: 10.3174/ajnr.A4713. Epub 2016 Mar 3.

16.

First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report.

Hall MD, Odia Y, Allen JE, Tarapore R, Khatib Z, Niazi TN, Daghistani D, Schalop L, Chi AS, Oster W, Mehta MP.

J Neurosurg Pediatr. 2019 Apr 5:1-7. doi: 10.3171/2019.2.PEDS18480. [Epub ahead of print]

PMID:
30952114
17.

Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.

Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR.

J Neurosurg. 2003 Nov;99(5):893-8.

PMID:
14609170
18.

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.

Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, James CD, Shilatifard A, Saratsis AM.

Acta Neuropathol Commun. 2017 Apr 17;5(1):28. doi: 10.1186/s40478-017-0436-6.

19.

Detection of H3K27M mutation in cases of brain stem subependymoma.

Yao K, Duan Z, Wang Y, Zhang M, Fan T, Wu B, Qi X.

Hum Pathol. 2019 Feb;84:262-269. doi: 10.1016/j.humpath.2018.10.011. Epub 2018 Oct 30.

PMID:
30389438
20.

Future of convection-enhanced delivery in the treatment of brain tumors.

Bidros DS, Liu JK, Vogelbaum MA.

Future Oncol. 2010 Jan;6(1):117-25. doi: 10.2217/fon.09.135. Review.

PMID:
20021213

Supplemental Content

Support Center